Aprea Therapeutics Inc Defensive Interval Ratio

Latest as of June 2019: 0 days

Aprea Therapeutics Inc defensive interval ratio. Aprea Therapeutics Inc (APRE) has a Defensive Interval Ratio of 0 days as of June 2019. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $0.00) cover 0 days of daily cash needs of $15.61K/day. See APRE current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

0 days
Days of operational coverage

Defensive Assets

$0.00
Cash + ST Investments + Receivables

Daily Cash Need

$15.61K
Current Liabilities ÷ 365

Current Liabilities

$5.70 Million
USD

Defensive Interval Ratio of Aprea Therapeutics Inc (2007–2018)

Defensive interval ratio of Aprea Therapeutics Inc from 2007 to 2018. This chart shows how Aprea Therapeutics Inc's Defensive Interval Ratio has evolved across 3 annual periods from 2007 to 2018. As of June 2019, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. Check Aprea Therapeutics Inc (APRE) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Aprea Therapeutics Inc Defensive Interval Ratio by Year (2007–2018)

Aprea Therapeutics Inc defensive interval ratio by year from 2007 to 2018. The table below presents the year-by-year Defensive Interval Ratio for Aprea Therapeutics Inc from 2007 to 2018, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see APRE total asset value.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2018 0 days $0.00 $13.34K/day $- $0.00 ▲ +0 days
2017 0 days $0.00 $11.78K/day $- $0.00 ▼ -2 days
2007 2 days $8.35K $4.46K/day $- $- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)